Description

Product details

Molnunat 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.

Keywords

• virus
• adults
• mild to
• moderate
• COVID-19
• December
• viral load
• Molnupiravir
• disease severity
• Molnunat 200mg Capsule
• emergency use approval
• first oral antiviral medication
• Indian drug regulatory authorities